Princeton, NJ, United States of America

Oscar Puig

This inventor holds 1 USPTO granted patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Oscar Puig. Retrieved from https://idiyas.com/inventor/oscar-puig-9q2cj2dl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Oscar Puig in M-Protein Assays

Introduction

Oscar Puig is an accomplished inventor based in Princeton, NJ (US). He has made significant contributions to the field of biological assays, particularly in the measurement of M-proteins. His work is crucial for diagnosing and monitoring plasma cell disorders, such as multiple myeloma.

Latest Patents

Oscar Puig holds a patent for M-protein assays. The patent discloses methods for measuring M-proteins in a biological sample obtained from a subject. This involves applying purified immunoglobulins to liquid chromatography (LC) mass spectrometry (MS). In certain aspects, the immunoglobulins are purified using immunocapture (IC). This innovative approach is particularly beneficial for subjects with plasma cell disorders.

Career Highlights

Oscar Puig is currently employed at Bristol-Myers Squibb Company, where he continues to advance his research in the field of immunology and diagnostics. His work has the potential to improve patient outcomes through more accurate and efficient testing methods.

Collaborations

Oscar collaborates with talented coworkers, including Rasa Santockyte and Jianing Zeng. Their combined expertise enhances the research and development efforts at Bristol-Myers Squibb.

Conclusion

Oscar Puig's innovative work in M-protein assays exemplifies the importance of research in advancing medical diagnostics. His contributions are vital for improving the understanding and treatment of plasma cell disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…